Skip to content

Maravai LifeSciences Holdings, Inc. MRVI Increase (Decrease) in Other Operating Assets

Increase (Decrease) in Other Operating Assets at other companies

Precigen logo
PrecigenPGEN
-$126K-325%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$1.74M+124%

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$902.74M+204%
Enterprise value$1.01B+198%
P/S4.4×+3.2×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s increase (decrease) in other operating assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s increase (decrease) in other operating assets?
Maravai LifeSciences Holdings, Inc. (MRVI) reported increase (decrease) in other operating assets of -$45.25K in Q4 2025.
How has Maravai LifeSciences Holdings, Inc.'s increase (decrease) in other operating assets changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s increase (decrease) in other operating assets decreased by 18.3% year-over-year, from -$38.25K to -$45.25K.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s increase (decrease) in other operating assets?
Over 2 years (2023 to 2025), Maravai LifeSciences Holdings, Inc.'s increase (decrease) in other operating assets has grown at a -54.2% compound annual growth rate (CAGR), from -$861K to -$181K.
What does increase (decrease) in other operating assets mean?
This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.